Merck announces pivotal Phase III study of Letermovir
The study evaluated the efficacy and safety of letermovir for the prevention of clinically-significant cytomegalovirus (CMV)…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.